TC-E 5003,PRMT1抑制剂
|
T288605-250mg
|
≥95% |
17328-16-4 |
250mg
|
¥ 522.9
|
现货 |
阿拉丁 |
TC-E 5003,PRMT1抑制剂
|
T288605-100mg
|
≥95% |
17328-16-4 |
100mg
|
¥ 349.9
|
现货 |
阿拉丁 |
4-溴芘
|
B152733-250mg
|
≥95% |
1732-26-9 |
250mg
|
¥ 530.9
|
现货 |
阿拉丁 |
9-(四氢-2-呋喃)腺膘呤
|
S138370-50mg
|
≥95% |
17318-31-9 |
50mg
|
¥ 679.9
|
现货 |
阿拉丁 |
9-(四氢-2-呋喃)腺膘呤
|
S138370-250mg
|
≥95% |
17318-31-9 |
250mg
|
¥ 1957.9
|
现货 |
阿拉丁 |
9-(四氢-2-呋喃)腺膘呤
|
S138370-10mg
|
≥95% |
17318-31-9 |
10mg
|
¥ 226.9
|
现货 |
阿拉丁 |
9-(四氢-2-呋喃)腺膘呤
|
S138370-100mg
|
≥95% |
17318-31-9 |
100mg
|
¥ 1144.9
|
现货 |
阿拉丁 |
甲基苯基乙烯基氯硅烷
|
C191531-100g
|
≥97% |
17306-05-7 |
100g
|
¥ 1875.9
|
现货 |
阿拉丁 |
LY 266097 盐酸盐
|
L286624-5mg
|
≥99%(HPLC) |
172895-39-5 |
5mg
|
¥ 1342.9
|
现货 |
阿拉丁 |
LY 266097 盐酸盐
|
L286624-25mg
|
≥99%(HPLC) |
172895-39-5 |
25mg
|
¥ 4588.9
|
现货 |
阿拉丁 |
LY 266097 盐酸盐
|
L286624-100mg
|
≥99%(HPLC) |
172895-39-5 |
100mg
|
¥ 11865.9
|
现货 |
阿拉丁 |
PP1
|
P126623-5mg
|
Moligand™, ≥98% |
172889-26-8 |
5mg
|
¥ 373.9
|
现货 |
阿拉丁 |
PP1
|
P126623-25mg
|
Moligand™, ≥98% |
172889-26-8 |
25mg
|
¥ 1241.9
|
现货 |
阿拉丁 |
PP1
|
P126623-100mg
|
Moligand™, ≥98% |
172889-26-8 |
100mg
|
¥ 3975.9
|
期货,请咨询 |
阿拉丁 |
甘氨酰-L-谷氨酰胺 一水合物
|
G167882-25g
|
≥97%(HPLC) |
172669-64-6 |
25g
|
¥ 264.9
|
期货,请咨询 |
阿拉丁 |
新吲哚菁绿(IR-820)
|
N119962-5g
|
Dye content 80% |
172616-80-7 |
5g
|
¥ 3042.9
|
现货 |
阿拉丁 |
2-(1-{[4-(羟基甲基)苯基]氨基}-3-甲基丁亚基)-5,5-二甲基-1,3-环己烷二酮
|
D333724-5g
|
≥98% |
172611-73-3 |
5g
|
¥ 3089.9
|
期货,请咨询 |
阿拉丁 |
2-(1-{[4-(羟基甲基)苯基]氨基}-3-甲基丁亚基)-5,5-二甲基-1,3-环己烷二酮
|
D333724-250mg
|
≥98% |
172611-73-3 |
250mg
|
¥ 277.9
|
现货 |
阿拉丁 |
艾普拉唑钠
|
I413292-50mg
|
≥98% |
172152-50-0 |
50mg
|
¥ 514.9
|
现货 |
阿拉丁 |
艾普拉唑钠
|
I413292-500mg
|
≥98% |
172152-50-0 |
500mg
|
¥ 2779.9
|
现货 |
阿拉丁 |
艾普拉唑钠
|
I413292-250mg
|
≥98% |
172152-50-0 |
250mg
|
¥ 1574.9
|
现货 |
阿拉丁 |
艾普拉唑钠
|
I413292-1g
|
≥98% |
172152-50-0 |
1g
|
¥ 4633.9
|
现货 |
阿拉丁 |
艾普拉唑钠
|
I413292-100mg
|
≥98% |
172152-50-0 |
100mg
|
¥ 833.9
|
现货 |
阿拉丁 |
1-甲基-1H-吡咯并[2,3-b]吡啶-3-羧酸
|
M174948-5g
|
≥97% |
171919-37-2 |
5g
|
¥ 682.9
|
现货 |
阿拉丁 |